EGRX ShortNice rounded top in EGRX... Liking a short here on this one as well. If it breaks through that support around $35 we could see a nice plunge.Shortby tyler_simPublished 1
$EGRX on Be prepared for possible GrowthAs Eagle Pharma Win Patent Decision for Bendeka, Court issued a favorable patent decision for Bendeka bendamustine hydrochloride injection, or bendamustine HCl , a liquid, low-volume and short-time 10-minute infusion formulation of bendamustine hydrochloride. So with that $EGRX shares rose 23% to $63.25 in premarket trading. With ongoing evaluation of the efficacy and safety of the medicament, $EGRX is showing a good and healthy growth at stock market. by LolipopBullsPublished 4
Eagle Pharmaceuticals on verge of breakout. Price entry $60 - target price $ 66 stop loss $58 Despite the stock been above the average analysts target we remain bullish om the setup technically, there is also the chance of upgrades to follow. P/E ratio 20.65 Short interest 14.62 % Quite High, but normal in the Pharma sector. Company profile Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ. Longby BullishchartsPublished 20
EAGLE PHARMA ready to break out. =============== SHORT TERM PRICE TARGET $68 +15% UPSIDE =============== Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.Longby BullishchartsPublished 7
EGRX flag break, looking for a follow through higher This just recently broke out of a flag pattern, so I'm going long tomorrow watching if it can keep going higher.Longby LivinPublished 1